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Background. Frailty is an age-associated biological syndrome and a predictor of multimorbidity outcomes, whose early rec-
ognition allows for the identification of those older patients at risk. The PRISMA-7 scale allows for the identification of frail older people.
Objectives. To make a cross-cultural adaptation and validation of the PRISMA-7 to the European spoken Portuguese language.
Material and methods. Cross-cultural adaptation by translation of the PRISMA-7 scale into European Portuguese, debriefing and back-
-translation to English. Application for intra-observer reliability assessment and validation by simultaneous and concurrent application 
of the Katz scale.
Results. Cronbach’s alpha coefficient was of 0.420 and 0.409 after a re-test. Spearman’s Rank Order Correlation of 0.969 in the re-test 
operation in a sample of 64 older people (35 female). More than 3 affirmative answers were found for older people (p < 0.001), for 
a higher number of self-reported drugs taken, (p = 0.001), self-reported years of education (p = 0.001), higher values for those with less 
years of studies were found in the validation of the translated PRISMA-7 scale, in a purposive sample of 127 older people, 72 (56.7%) 
female. No differences were found between gender (p = 0.414) and for number of self-reported diseases (p = 0.258). A Spearman cor-
relation of ρ = 0.477 (p < 0.001) between the total of the two scales was found.
Discussion. This comprehensive tool enables health care providers to discuss and architect more effective and efficient measures for 
these patients’ care, regardless of gender, socio-demographic factors, number of self-reported drugs taken and diseases.
Conclusions. The PRISMA-7 scale is now recommended to identify frail older people in the Portuguese community. 





This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International 
(CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/).
Santiago LM, Silva R, Velho D, Rosendo I, Simões JA. Cross-cultural adaptation and validation of the PRISMA-7 scale for European Por-
tuguese. Fam Med Prim Care Rev 2020; 22(1): 59–66, doi: https://doi.org/10.5114/fmpcr.2020.92507.
https://doi.org/10.5114/fmpcr.2020.92507 
Background
The ageing population poses new challenges for health 
and social care services [1–6]. The increase in life expectancy 
is inversely associated with healthy life expectancy, implying 
a longer lifespan with disability and, therefore, increased use 
of health care, multimorbidity and frailty [2, 7]. The group of 
frail older people is increasing due to ageing and an increase 
in life expectancy [6]. A high percentage of emergency patients 
are frail older patients, and they are the fastest growing group 
in primary care [6, 8, 9].
Frailty is an age-associated biological syndrome with mul-
tisystem down-dysregulation, reduced physiological reserves 
[7–11] and capacity to maintain homeostasis [1, 12–17], loss 
of cognitive function [18], functional decline [5, 6], increased 
risk of being institutionalised [19] and vulnerability to stressors 
[9–11, 13–15, 20], risk of falls, disability, dependence [4, 18], 
activity limitations, imminent death, hospitalisation, prolonged 
recovery and relapse [1, 8, 16, 19, 21–25]. Frail older patients 
present a long clinical course of disease with intermittent epi-
sodes of decline and experiencing a lack of coping strategies 
when dealing with change and disruptions [2, 19]. Very old 
patients evaluate their health problems based on impact [26]. 
Interactions between physiological changes due to ageing, poly-
pharmacy, multimorbidity and functional impairment are often 
complex [21].
Frailty is more prevalent in developing countries and is as-
sociated with socio-demographic variables, such as gender and 
age [14]. The incidence of frailty increases with age, lower edu-
cation and income, poor health, multimorbidity and disability 
and is higher in women and in Afro-Americans [11].
A high percentage of frail older patients suffering from mul-
timorbidity and recurrent acute illnesses is treated in special-
ised acute care units [5, 6, 8, 21]. After discharge, older patients 
have a higher risk of mortality, and approximately one-third of 
older patients experience a loss of independence in self-care ac-
tivities, including personal and instrumental activities of daily 
living, which are related with poor nutrition, loss of sphincter 
control, and decreased self-care and low mobility during hospi-
talisation [18, 21]. Functional decline is associated with worse 
outcomes of health-related quality of life, less living at home, 
more re-hospitalisations and higher health costs, which result 
in the use of more expensive and intensive services and higher 
mortality [18, 21, 27].
Frailty is a predictor and an outcome of multimorbidity 
needing to be diagnosed early [1, 23]. Functional status assess-



























ment in geriatric practice is important for early diagnosis, as it 
has implications in prognosis, as well as in optimising care, plan-
ning interventions and preventing the progression of frailty [17, 
18, 23, 28]. 
Several frailty instruments evaluate weakness, slowness, 
low physical activity, unintentional weight loss, accumulation of 
deficits and exhaustion, which are aspects of the clinical pheno-
type of frailty that should be diagnosed with no delay [8–10, 13, 
14, 16, 21–24, 27]. 
Comprehensive geriatric assessment, treatment and rehabili-
tation is associated with decreased mortality, less functional de-
cline at discharge, reduced care needs and a higher probability of 
living at home [3, 5, 8, 13, 21]. Thus, to adequately prevent hos-
pitalisation, we need to study ambulatory older people with an 
adequate instrument to prevent delay of functional decline [29].
The Program on Research for Integrating Services for the 
Maintenance of Autonomy (PRISMA) was developed in Canada 
in 2005 [29]. The PRISMA model includes the PRISMA-7 ques-
tionnaire, validated to screen for frailty, which allows services 
to be adapted to clients’ needs [29, 30]. PRISMA-7 identifies risk 
factors for functional decline through seven dichotomous items 
[29, 31]. 
In the Canadian study, PRISMA-7 had 78% sensitivity and 
75% specificity with a cut-off point of three or more positive 
answers for identification of functional decline in older patients, 
and 61% sensitivity and 91% specificity with a cut-off point of 
four or more positive answers [30]. Due to the good perfor-
mance of PRISMA-7 in comparison with other frailty assessment 
instruments, the Royal College of General Practitioners and the 
British Geriatrics Society recommend PRISMA-7 for frailty iden-
tification [29, 31].
The Katz scale is an index of independence in daily life ac-
tivities, developed by Sidney Katz, and is one of the mostly used 
instruments in geriatric evaluation [32]. The scale measures hi-
erarchically related activities of daily living and allows for the 
evaluation of independence in the execution of six daily life 
functions [32]. The Katz scale allows for the monitoring of the 
evolution of disability through ageing, as well as of the progno-
sis, intervention planning and evaluation of the effectiveness of 
performed treatments [32].
Daily life activities are influenced by one’s culture and are 
determined by behaviour, cultural norms and values, making 
cross-cultural validation of scales important in research [28].
Objectives
This study aims to make the cross-cultural adaptation and 
validation of the PRISMA-7 scale, assessing its psychometric 
properties concurrently with another well-known health related 
scale, the Katz scale.
Material and methods
The study was made in accordance to an health ethics com-
mitee aproved protocol.
according to the “Program of Research to integrate Services 
for the Maintenance of Autonomy (PRISMA)” being over 85 years, 
being a male, suffering from health limiting problems, needing 
regular help for daily activities or being restricted at home, need-
ing help to move around or to perform daily hygiene are factors to 
punctuate in a dichotomous instrument, valuing more than three 
positive answers as frailty. The scale is shown in Table 1.
The study’s first phase was the cross-cultural adaptation to 
Portuguese language of the PRISMA-7 scale, which was then back-
translated from English [30] to European Portuguese. The original 
English scale consists of seven dichotomous questions, since the 
intended answer is a yes or no response, as shown in Table 1.
The translation was made by two people, fluent in techni-
cal English language, whose mother tongue is Portuguese. This 
translation was then retranslated into English by a bilingual 
Portuguese/English teacher, who did not have any information 
about the concepts and objectives of the questionnaire. The 
purpose of the retranslation was to verify the popular use of 
the source language and to correct any ambiguous meanings of 
the original questionnaire. A debriefing was then undertaken by 
three medical doctors to verify the compatibility of the Portu-
guese wording to the English original.
Table 1. PRISMA-7 original English version [30]
Questions Answer
Yes No
P1: Are you older than 85 years?
P2: Are you male?
P3: In general, do you have any health problems 
that require you to limit your activities?
P4: Do you need someone to help you regularly?
P5: In general, do you have any health problems 
that require you to stay at home?
P6: If you need help, can you count on someone 
close to you?
P7: Do you regularly use a cane, a walker, or 
a wheelchair to move about?
□    □
□    □
□    □
□    □
□    □
□    □
□    □
Subsequently, in the second phase of the study, the Portu-
guese version of the PRISMA-7 scale was applied in two different 
moments to evaluate the scale’s intra-observer reliability (test/ 
/re-test). An epidemiological scale was simultaneously applied 
in the first moment. Both scales were self-administered, with 
a guarantee of anonymity and confidentiality after informed 
consent to persons older than 64 years, of whom 35 were fe-
male, selected from the ambulatory care on the island of São 
Miguel, azores, and in Portugal central mainland in the city of 
Coimbra. For test/re-test reliability analysis, Chronbach’s alpha 
coefficient was used, and Spearman’s Rank Order Correlation 
was used to calculate the strength of the relationship between 
the results obtained in the two different moments. The Mann– 
–Whitney U Test was used to test differences between the re-
sults obtained in the two different moments, and the chi-square 
test for Independence was used to explore the relationship be-
tween socio-demographic variables [33]. We also performed 
a study on the level of literacy and the perceptibility of the scale.
The study’s third phase aimed to validate the PRISMA-7 scale 
with the Katz scale. The questionnaire was applied to 127 older 
people in the same health units. Simultaneously, an epidemio-
logical scale was also self-administered, guaranteeing anonymity 
and confidentiality after informed consent. For analysis of the 
results, the Mann–Whitney U Test was used to test for differ-
ences between socio-demographic variables and the number of 
affirmative answers on the PRISMA-7 scale, Pearson’s correlation 
was used to explore the strength of the relationship between 
PRISMA-7 and the Katz scale, and the chi-square test for Inde-
pendence was used to explore the relationship between socio-
demographic variables. A p < 0.001 value was used to address 
statistical difference [33], and a cut-off value of three affirma-
tive answers was defined for study use. The presence of three or 
more affirmative answers will allow for the diagnosis of frailty.
Results
Study phase 1: The cross-cultural adaptation to Portuguese 
was made according to the methodology previously described 
and ended with the results shown in Table 2.
Study phase 2: Table 3 shows the socio-demographic char-
acteristics of the purposive phase 2 sample of 64 older people, 
of whom 35 (54.7%) were female. Women were older than 
men, reported more simultaneous diseases and medications 
and had less years of education. These last three items showed 
a statistical difference.



























Cronbach’s alpha coefficient, scale mean and variation and cor-
rected item total correlation. All items had 64 answers, except 
for items 1 and 3, which had 63 answers. Item 6 had the low-
est scale mean in the test and the re-test (1.0938 and 1.1094, 
respectively). Item 7 had the highest mean in the test and the 
re-test (1.6563 and 1.6406, respectively). Items 1, 3 and 5 had 
the lowest difference in the scale variation between test and 
re-test. Item 6 had the highest difference in the scale variation 
Table 2. Translation of PRIMA 7 into Portuguese spoken in Europe
Questões Resposta
Sim Não
Tem mais de 85 anos?
É do sexo masculino?
Em geral, tem algum problema de saúde que o/a obrigue a diminuir ou limitar as suas atividades?
Precisa da ajuda de alguém regularmente? 
Em geral, tem algum problema de saúde que o/a obrigue a ficar em casa?
Se precisar de ajuda, tem alguém próximo para o/a ajudar?
Utiliza regularmente bengala, andarilho ou cadeira de rodas?
□     □
□     □
□     □
□     □
□     □
□     □
□     □





65–75 years count 15 12 27
gender % 51.7% 34.3% 42.2%
76–85 years count 3 3 6
gender % 10.3% 8.6% 9.4%
equal or greater 
than 86 years
count 11 20 31
gender % 37.9% 57.1% 48.4%
number of self-reported 
diseases 
p < 0.001
up to 2 diseases count 21 11 32
gender % 72.4% 31.4% 50.0%
3 to 4 diseases count 6 11 17
gender % 20.7% 31.4% 26.6%
4 to 6 diseases count 1 8 9
gender % 3.4% 22.9% 14.1%
greater than 6 
diseases
count 1 5 6
gender % 3.4% 14.3% 9.4%
number of self-reported 
drugs taken 
p < 0.001
up to 2 drugs count 8 1 9
gender % 27.6% 2.9% 14.1%
3 to 4 drugs count 9 6 15
gender % 31.0% 17.1% 23.4%
4 to 6 drugs count 6 12 18
gender % 20.7% 34.3% 28.1%
greater than 6 drugs count 6 16 22
gender % 20.7% 45.7% 34.4%
Self-reported years of 
education
p < 0.001
less than 4 years count 4 19 23
gender % 13.8% 54.3% 35.9%
4 years count 20 14 34
gender % 69.0% 40.0% 53.1%
7 years count 5 1 6
gender % 17.2% 2.9% 9.4%
greater than 7 years count 0 1 1
gender % 0.0% 2.9% 1.6%
Total count 29 35 64
gender % 100.0% 100.0% 100.0%
Table 4 shows the assessment of internal consistency and 
the strength of the relationship between the results obtained 
in the two different moments. Cronbach’s alpha coefficient pre-
sented a test value of 0.420 and a re-test value of 0.409, and 
Spearman’s Rank Order Correlation (rho) presented a test value 
of 1.000 and a re-test value of 0.969.
Table 5 shows the assessment of internal consistency for 
each item applied in the two different moments, based on 



























in the test and re-test. Cronbach’s alpha coefficient varied be-
tween 1.000 and 0.906 (items 1 and 4, respectively).
Perceptibility by the Flesher instrument was 75.11, meaning 
the scale was relatively easy to understand.
 For the study’s third phase, Table 6 shows the socio-demo-
graphic characteristics of the purposive sample. We found no 
differences by gender for the studied variables. 
Table 7 shows Katz and PRISMA-7 statistics, class “indepen-
dence” being the most frequent (n = 75, 59.1%) for the Katz In-
dex. For PRISMA-7, 46 (36.2%) of the respondents had three or 
more positive answers.
Table 8 shows the distribution of the results on the Katz 
scale according to the three affirmative answer cut-off on the 
Table 4. Test and re-test reliability statistics for the study’s second phase
Test reliability statistics Retest reliability statistics Spearman’s rho in test/re-test
Cronbach’s alpha Number of items Cronbach’s alpha Number of items Test Re-test
0.420 7 0.409 7 1.000 0.969
Table 5. Item statistics for the study’s second phase
Item Scale mean if item 
deleted





Cronbach’s alpha Number of items
P1 1.5156 0.254 1.000
1.000 2
P1.1 1.5156 0.254 1.000
P2 1.3906 0.242 0.937
0.968 2
P2.1 1.4219 0.248 0.937
P3 1.2698 0.200 0.919
0.958 2
P3.1 1.2698 0.200 0.919
P4 1.4531 0.252 0.906
0.951 2
P4.1 1.4688 0.253 0.906
P5 1.5000 0.254 0.969
0.984 2
P5.1 1.4844 0.254 0.969
P6 1.0938 0.086 0.918
0.956 2
P6.1 1.1094 0.099 0.918
P7 1.6563 0.229 0.966
0.983 2
P7.1 1.6406 0.234 0.966





65–75 years count 27 30 57
gender % 49.1% 41.7% 44.9%
76–85 years count 16 22 38
gender % 29.1% 30.6% 29.9%
equal or greater than 86 
years
count 12 20 32
gender % 21.8% 27.8% 25.2%
number of  self-reported 
diseases
p = 0.192
up to 2 diseases count 24 24 48
gender % 43.6% 33.3% 37.8%
3 to 4 diseases count 19 25 44
gender % 34.5% 34.7% 34.6%
4 to 6 diseases count 6 15 21
gender % 10.9% 20.8% 16.5%
greater than 6 diseases count 6 8 14
gender % 10.9% 11.1% 11.0%
PRISMA-7 frailty scale. We found a statistically significant asso-
ciation between the level of dependence and the diagnosis of 
frailty (p < 0.001). We also found a Spearman’s correlation of ρ = 
0.477 (p < 0.001) between the total of the two scales.
Table 9 shows PRISMA-7 classes and socio-demographic 
statistics for the study’s third phase. There were more individu-
als with less than three affirmative answers (81, 63.8%). In the 
group of frail individuals (three or more affirmative answers on 
the PRISMA-7 scale), we found more women (54.3%, ns), more 
people from the oldest age group (52.2%, p < 0.001), more self-
reported multimorbidity, with four or more diseases (34.8%, ns), 
more self-reported medicines, taking 4 or more drugs (73.9%, 
ns), and less education, 4 or less years (86.9%, ns).

































up to 2 drugs count 10 12 22
gender % 18.2% 16.7% 17.3%
3 to 4 drugs count 13 15 28
gender % 23.6% 20.8% 22.0%
4 to 6 drugs count 14 24 38
gender % 25.5% 33.3% 29.9%
greater than 6 drugs count 18 21 39




less than 4 years count 7 31 38
gender % 12.7% 43.1% 29.9%
4 years count 31 26 57
gender % 56.4% 36.1% 44.9%
7 years count 7 2 9
gender % 12.7% 2.8% 7.1%
greater than 7 years count 10 13 23
gender % 18.2% 18.1% 18.1%
Total count 55 72 127
gender % 100.0% 100.0% 100.0%
Table 7. Katz statistics for the study’s third phase
Katz classes Frequency Valid percentage
total dependence 5 3.9%
Severe dependence 4 3.1%
Moderate dependence 12 9.4%
Slight dependence 31 24.4%
independence 75 59.1%
Prisma 7
Three or more affirmative answers 46 36.2%
Table 8. PRISMA-7 and Katz statistics for the study’s third phase
PRISMA-7* Total
Three or more affirmative 
answers
Less than three affirmative 
answers
Katz total dependence count 5 0 5
percentage 10.9% 0% 3.9%
Severe dependence count 4 0 4
percentage 8.7% 0% 3.1%
Moderate dependence count 8 4 12
percentage 17.4% 4.9% 9.4%
Slight dependence count 16 15 31
percentage 34.8% 18.5% 24.4%
independence count 13 62 75
percentage 28.3% 76.5% 59.1%
Total count 46 81 127
percentage 100.0% 100.0% 100.0%
* p < 0.001.



























Table 9. PRISMA-7 classes and socio-demographic statistics for the study’s third phase
PRISMA-7 Total
Three or more affirmative 
answers




male count 21 34 55
percentage 45.7% 42.0% 43.3%
female count 25 47 72
percentage 54.3% 58.0% 56.7%
age
p < 0.001
65–75 years count 11 46 57
percentage 23.9% 56.8% 44.9%
76–85 years count 11 27 38
percentage 23.9% 33.3% 29.9%
equal or greater 
than 86 years
count 24 8 32




up to 2 diseases count 15 33 48
percentage 32.6% 40.7% 37.8%
3 to 4 diseases count 15 29 44
percentage 32.6% 35.8% 34.6%
4 to 6 diseases count 11 10 21
percentage 23.9% 12.3% 16.5%
greater than 6 
diseases
count 5 9 14





up to 2 drugs count 3 19 22
percentage 6.5% 23.5% 17.3%
3 to 4 drugs count 9 19 28
percentage 19.6% 23.5% 22.0%
4 to 6 drugs count 12 26 38
percentage 26.1% 32.1% 29.9%
greater than 6 drugs count 22 17 39




less than 4 years count 22 16 38
percentage 47.8% 19.8% 29.9%
4 years count 18 39 57
percentage 39.1% 48.1% 44.9%
7 years count 2 7 9
percentage 4.3% 8.6% 7.1%
greater than 7 years count 4 19 23
percentage 8.7% 23.5% 18.1%
Total count 46 81 127
percentage 100.0% 100.0% 100.0%
Discussion
According to prior studies for cross-cultural adaptation and 
validation, the internal consistency assessed by Cronbach’s alpha 
showed a borderline value, probably because of the length of 
the questionnaire. It should be highlighted that this scale is more 
of an objective matrix registry than a scale measuring intrinsic 
variable subjective values about someone’s opinion on a subject. 
In the evaluation of the internal consistency of the test, Se-
anger et al. [29] obtained a Cronbach’s alpha coefficient value 
of 0.619, which is higher than that obtained in this study (Cron-
bach’s alpha coefficient of 0.420). This difference may be due 
to differences in sample size and intrinsic characteristics. The 
study of Seanger et al. [29] does not present the value of the 
Cronbach’s alpha coefficient for the re-test.
This is a valid European Portuguese version of the PRISMA-7 
scale, which is easy to understand.
in the second phase of the study, the Cronbach’s alpha co-
efficient denotes internal consistency and reliability, and the 
Spearman’s Rank Order Correlation indicates a positive associa-
tion between the results obtained in the test and re-test of the 
translation of the PRISMA-7 scale.
in the third phase of the study, most of the older people in-
terviewed were aged between 65 and 75 years and had 4 years 
or less of education. The high number of self-reported drugs 
taken daily reflected the health status of older people that ac-
cess primary health care services. 
The identification of frail older people with the PRISMA-7 
scale was, significantly, in accordance with the classification of 
functionality of the Katz scale, since, for dependency classifica-



























tions on the Katz scale, there was a higher number of individuals 
with three or more affirmative answers on the PRISMA-7 scale, 
and simultaneously, for the independence classification on Katz 
scale, there was a higher number of individuals with less than 
three affirmative answers on the PRISMA-7 scale. 
In both genders, there were similar percentages of three or 
more affirmative responses, indicating that the PRISMA-7 scale 
allows for the identification of frail older people regardless of 
gender. 
The PRISMA-7 scale was sensitive to the socio-demographic 
factors: an increase in age and in the number of self-reported 
drugs taken daily was associated with an increase in the num-
ber of individuals with three or more affirmative answers; a de-
crease in the number of self-reported diseases was associated 
with a decrease in the number of individuals with three or more 
affirmative answers; and an increase in the number of years of 
education was associated with a decrease in the number of in-
dividuals with 3 or more affirmative answers.
As in the study of Seanger et al. [29], the sample of this 
study had a diversity of socio-demographic characteristics, al-
lowing for the evaluation of its applicability in different age 
groups.
For the PRISMA-7 class of three or more affirmative an-
swers, Seanger et al. [29] obtained a higher percentage of indi-
viduals in the age group of 60 to 74 years, while in the present 
study, the age group with the highest percentage was equal or 
higher than the age group of 86 years. This may be due to differ-
ences in cultural characteristics and the time lapse between the 
two studies. For educational level and gender, both papers pres-
ent a higher percentage of individuals of the female gender and 
in the group with less than 4 years of education. These results 
are in accordance with the risk of greater frailty in these groups.
The results indicate that the PRISMA-7 scale has the sensi-
tivity to detect people between the ages of 65 and 85 at risk of 
frailty, and thus it can be used to identify people at risk of frailty 
early in this age group, widening the target population for which 
it is intended. In this way, it will allow the timely implementation 
of health services with the aim of preventing the emergence 
of fragility syndrome, contributing to the improvement of qual-
ity of life and increased independence, which will consequently 
contribute to the reduction of consumption and expenditures 
of health services.
The PRISMA-7 scale, being specific for the identification of 
fragility syndrome, may be an important tool for the follow-up, 
prognosis and evaluation of the effectiveness of the treatments 
provided.
In the presence of fragility syndrome, it would be pertinent 
to verify if the PRISMA-7 scale would also be a useful tool to 
evaluate caregivers’ perceptions of a person’s frailty. Knowledge 
of caregivers’ perceptions could contribute to early identifica-
tion of the need for community service support.
Conclusions
The PRISMA-7 scale has been adapted and validated to the 
European spoken Portuguese language. The results of this study 
suggest the adequacy of the validation process and the effec-
tiveness in early identification of frail older patients. The PRIS-
MA-7 version for European Portuguese is a simple, easy to apply 
and reliable tool for discovering and implementing preventive 
and rehabilitation health services for frail older people. There-
fore, it is recommended as a tool to identify frail older people 
in the community. 
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